These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17030571)

  • 21. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
    Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ
    Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Francisella tularensis genes encoding exported membrane-associated proteins using TnphoA mutagenesis of a genomic library.
    Gilmore RD; Bacon RM; Sviat SL; Petersen JM; Bearden SW
    Microb Pathog; 2004 Oct; 37(4):205-13. PubMed ID: 15458781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol.
    Santic M; Molmeret M; Barker JR; Klose KE; Dekanic A; Doric M; Abu Kwaik Y
    Cell Microbiol; 2007 Oct; 9(10):2391-403. PubMed ID: 17517064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS).
    Sammons-Jackson WL; McClelland K; Manch-Citron JN; Metzger DW; Bakshi CS; Garcia E; Rasley A; Anderson BE
    DNA Cell Biol; 2008 Jul; 27(7):387-403. PubMed ID: 18613792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2.
    Qin A; Mann BJ
    BMC Microbiol; 2006 Jul; 6():69. PubMed ID: 16879747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen.
    Conlan JW; Vinogradov E; Monteiro MA; Perry MB
    Microb Pathog; 2003 Jan; 34(1):39-45. PubMed ID: 12620383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to
    Stefanetti G; Okan N; Fink A; Gardner E; Kasper DL
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7062-7070. PubMed ID: 30872471
    [No Abstract]   [Full Text] [Related]  

  • 28. Deletion of the Major Facilitator Superfamily Transporter
    Balzano PM; Cunningham AL; Grassel C; Barry EM
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311235
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative proteome analysis of fractions enriched for membrane-associated proteins from Francisella tularensis subsp. tularensis and F. tularensis subsp. holarctica strains.
    Pavkova I; Reichelova M; Larsson P; Hubalek M; Vackova J; Forsberg A; Stulik J
    J Proteome Res; 2006 Nov; 5(11):3125-34. PubMed ID: 17081064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines against Francisella tularensis.
    Wayne Conlan J; Oyston PC
    Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
    Clay CD; Soni S; Gunn JS; Schlesinger LS
    J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice.
    Hartley G; Taylor R; Prior J; Newstead S; Hitchen PG; Morris HR; Dell A; Titball RW
    Vaccine; 2006 Feb; 24(7):989-96. PubMed ID: 16257097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge.
    Tempel R; Lai XH; Crosa L; Kozlowicz B; Heffron F
    Infect Immun; 2006 Sep; 74(9):5095-105. PubMed ID: 16926401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mutations in Francisella tularensis, decreasing the virulence of these bacteria and leading to a change in the immune response upon infection of experimental animals with them].
    Aleshkin GI; Komissarova LV; Savel'eva RA; Zakharenko VI; Loginskiĭ PIu; Skavronskaia AG
    Mol Gen Mikrobiol Virusol; 1992; (1-2):23-9. PubMed ID: 1620153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heat-shock protein ClpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice.
    Meibom KL; Dubail I; Dupuis M; Barel M; Lenco J; Stulik J; Golovliov I; Sjöstedt A; Charbit A
    Mol Microbiol; 2008 Mar; 67(6):1384-401. PubMed ID: 18284578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Culkin SJ; Rhinehart-Jones T; Elkins KL
    J Immunol; 1997 Apr; 158(7):3277-84. PubMed ID: 9120284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW
    Future Microbiol; 2011 Apr; 6(4):391-405. PubMed ID: 21526941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of subspecies of Francisella tularensis.
    Svensson K; Larsson P; Johansson D; Byström M; Forsman M; Johansson A
    J Bacteriol; 2005 Jun; 187(11):3903-8. PubMed ID: 15901721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.
    Conlan JW; Shen H; Webb A; Perry MB
    Vaccine; 2002 Oct; 20(29-30):3465-71. PubMed ID: 12297391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.